BioSpace News Archive

Veeva Systems announced that Roche has selected Veeva Development Cloud applications globally to streamline clinical, regulatory, and quality processes.

New data demonstrate a sustained patient benefit following SER-109 administration with a highly statistically significant 31.1% absolute reduction in the rate of C. difficile infection recurrence over 12 weeks, compared to placebo

Authored by esteemed experts in immunology and leaders at the forefront of inflammasome research at University of Miami Miller School of Medicine

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting, and anti-theft tech

Reflect Scientific, Inc., is a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries.

AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced a new appointment to initiate integration efforts resulting from the July 31, 2020 acquisition of MolMed, a biotechnology company focused on research, development, production and clinical validation of cell and gen

Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapies in oncology and hematology, announced today, the official opening of the Antengene’s New Drug Discovery Center based in Zhangjiang, Shanghai . The opening cer

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, will present two abstracts relating to its first product, the Nu.Q™ Vet Cancer Screening Test, at the 2020

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today highlighted a new segment of “Behind the Mystery” focused on glioblastoma from The Balancing Act airing on Li

Fresenius Medical Care North America (FMCNA) , the nation’s leading renal care company, celebrates National Dialysis Technician Recognition Week by announcing a new collaboration wit